21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#602Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
#603Therapy and prevention of prion protein complex infections in non-human animals
#604Methods of using c-Met modulators
#605Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
#606Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
#607Compositions for treating spinal muscular atrophy
#608Supporting immunomodulatory agent
#609RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#610Compositions and methods for treatment of homocystinuria
#611Bis-amines, compositions, and uses related to CXCR4 inhibition
#612Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#613Lipid disulfide prodrugs and uses related thereto
#614Indolin-2-one derivatives
#615Peptides and method for treatment of cardiac arrest
#616Apilimod compositions and methods for using same in the treatment of renal cancer
#617Tumor infiltrating lymphocytes and methods of therapy
#618AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
#619Riluzole prodrugs and their use
#620Materials and methods for controlling infections
#621Compositions and methods for treatment of homocystinuria
#622Combination immunotherapies for treatment of cancer
#623COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND AN INTERFERON
#624METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME
#625Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#626Antibiotic solution and method of injection to prevent ophthalmic infections
#627DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION
#628Altering microbial populations and modifying microbiota
#629APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#630PTGDR-1 and/or PTGDR-2 antagonists for preventing and/or treating systemic lupus erythematosus
#631Blended cannabis compounds and methods of making the same
#632METHODS AND COMPOSITIONS FOR EXTENDING LIFESPAN
#633Antiproliferative compounds and methods of use thereof
#634Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#635Extended release methazolamide formulation
#636Skin care composition and method of making a skin care composition
#637Collagen peptide-based medicament compositions and devices and methods of production and use thereof
#638THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD
#639Drug combination with antitumor effects
#640TREATMENT OF ADVANCED HER2 EXPRESSING CANCER
#641Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment
#642Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#643Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
#6445-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
#645Chemotherapeutic methods for treating low-proliferative disseminated tumor cells
#646Therapeutic methods and compositions
#647Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
#648COMPOSITION AND MEDICAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT
#649Biophotonic compositions for the treatment of otitis externa
#650Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
#651Method of treating or preventing Ras-mediated diseases
#652Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#653Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#654Topical ocular preparation of botulinum toxin for use in ocular surface disease
#655METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#656USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY
#657Formulations and methods for the treatment of cancers
#658SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS
#659Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#660Combination therapies for treatment of cancer
#661Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus
#662Compositions and methods for treating diseases of the nail
#663Inhibitors of KRAS G12C and methods of using the same
#664Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
#665BACTERIAL POPULATIONS FOR PROMOTING HEALTH
#666Hypochlorous acid formulations and methods for treating skin conditions
#667Composition and method for treatment of depression and psychosis in humans
#668USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#669BISPHENOL ETHER DERIVATIVES AND METHODS FOR USING THE SAME
#670ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#671Anti-CD276 antibodies (B7H3)
#672Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
#6734′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
#674Therapeutical methods, formulations and nutraceutical formulations
#675Methods of treating advanced prostate cancer
#676COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES
#677METHODS OF ADMINISTERING ANTI-TNFALPHA ANTIBODIES
#678Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#679Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#680ANTI-PATHOGENIC COMPOSITIONS
#681Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#682COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION
#683THERAPEUTIC REGIMEN
#684OXYBUTYNIN-XANOMELINE TRANSDERMAL THERAPEUTIC SYSTEM COMBINATIONS
#685Methods for inducing cell division of postmitotic cells
#686Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#687Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#688Drug releasing coatings for balloon catheters
#689Compositions and methods for treating multiple sclerosis
#690Bromodomain and extra-terminal protein inhibitor combination therapy
#691METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL TOXICITY
#692METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS
#693Macrocyclic compound and uses thereof
#694Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
#695Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#696Use of kinase inhibitors to manage tuberculosis and other infectious diseases
#697Azetidine derivative, preparation method therefor, and use thereof
#698Milrinone controlled-release formulation
#699Formulations for oral administration of active agents
#700RAR selective agonists in combination with immune modulators for cancer immunotherapy
#701Compositions and methods for treating and preventing infections
#702Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#703Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#704COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#705THERAPY FOR KINASE-DEPENDENT MALIGNANCIES
#706ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#707Combined preparations for the treatment of cancer or infection
#708NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS
#709METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY
#710NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID
#711GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS
#712Extended relief dosage form
#713Method of identifying a biologically-active composition from a biofilm
#714Therapy and prevention of prion protein complex infections in non-human animals
#715INHIBITORS OF BRUTON'S TYROSINE KINASE
#716AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
#717Heterocyclic inhibitors of ATR kinase
#718ExPEC glycoconjugate vaccine formulations
#719Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
#720Combination therapy for treatment of restenosis
#721Diindole compounds useful in treatment of nervous system disorders
#722Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
#723USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#724Bispecific EGFR/C-Met Antibodies
#725Acylated glucagon analogue
#726Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB
#727COMBINATION OF CERTINIB WITH AN EGFR INHIBITOR
#728Riluzole prodrugs and their use
#729ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#730Treatment for multiple myeloma (MM)
#731PHARMACEUTICAL COMPOSITION CONTAINING CELECOXIB
#732Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#733ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#734Aminothiazole compounds and methods using same
#735Vaginal inserted estradiol pharmaceutical compositions and methods
#736METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY
#737ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#738Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#739Bi-specific antibodies and uses thereof
#740Antioxidant dietary supplement compositions
#741TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#742PSMA-RELATED THERAPIES
#743Combination therapies for treatment of cancer
#744Treatment methods and processes for an infected nail
#745Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#746METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
#747Reduction of milk glycans and their degradation products in the neonate gut
#748ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME
#749Antibiotic solution and method of injection to prevent ophthalmic infections
#750Method of treatment for ketamine infusion
#751Methods For Treating Cancer
#752Immunologic treatment of cancer
#753FORMULATIONS, METHODS, KIT, AND DOSAGE FORMS FOR TREATING BACTERIAL INFECTION
#754Inhibition of protein disulfide-isomerase A3
#755Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#756Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#757Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms
#758Methods for treating cancer
#759Compositions and methods for inhibiting kinases
#760Process for synthesis of eliglustat and intermediate compounds thereof
#761Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#762METHOD OF TREATING NEOPLASIAS
#763Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#764Cannabidiol (CBD) Formulation Including Caprylic Acid
#765Human antibodies to influenza hemagglutinin
#766Inhibitors of cyclin-dependent kinase 7 (CDK7)
#767Salt of a pyrimido[6,1-A]isoquinolin-4-one compound
#768COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#769Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
#770Pharmaceutical quality strontium L-lactate
#771NRF2 Screening Assays and Related Methods and Compositions
#772Buffered microencapsulated compositions and methods
#773Methods of treating skin cancer by administering a PD-1 inhibitor
#774ODOR CONTROL AGENT
#775Combination therapy comprising Varlitinib and an anticancer agent
#776COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES
#777COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SCHISTOSOMIASIS
#778Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#779Methods of reducing neuronal injury or toxicity in epilepsy, Alzheimer's disease or Parkinson's disease using a scorpion venom heat-resistant synthetic peptide (SVHRSP)
#780COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS
#781THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS
#782Systems and methods for treating cancer
#783Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions
#784ZEAXANTHIN FOR TUMOR TREATMENT
#785System for providing an up-to-date and long-acting or ultra-long-acting insulin dose guidance recommendation to treat diabetes mellitus
#786Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels
#787Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#788Methods and compositions for the activation of gamma-delta T-cells
#789Dosage form for treating severe asthma
#790Drug compositions
#791COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES AND SIDE-EFFECTS ASSOCIATED WITH COGNITION EFFECTING PHARMACEUTICALS
#792NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO
#793METHOD OF TREATING LOWER TRACT UROTHELIAL CANCER
#794PHARMACEUTICAL COMPOSITION AND METHOD FOR ACUTE ON CHRONIC LIVER FAILURE AND RELATED LIVER DISEASES
#795DBH inhibitors for treating or preventing memory loss
#796Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#797Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods
#798Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
#799COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#800COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#801Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#802COMPOSITIONS AND METHODS FOR TREATING VARICOSE VEINS
#803USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#804Sublingual films
#805Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide
#806SYNERGISTIC INIHIBITION OF TUMOR CELL PROLIFERATION INDUCED BY COMBINED TREATMENT OF METFORMIN OR METFORMIN ANALOGS AND IRON CHELATORS
#807PAC-1 combination therapy
#808MEDICINE COMBINATIONS AND TREATMENT OF RESTLESS LEG SYNDROME
#809Method for the treatment of human melanoma
#810Treatment of angiogenesis disorders
#811Nutraceutical gels
#812Compositions for treatment of arthritis
#813COMBINATIONS COMPRISING 3-PHENYLSULFONYL-8-PIPERAZINYL-1YL-QUINOLINE
#814Combination drug therapy reduces PARP-1 related DNA repair and increases the efficacy of genotoxic agents
#815Lasofoxifene modulation of membrane-initiated estrogen signals and methods for tumor treatment
#816Compositions and methods useful for the prevention of malaria and dengue virus transmission
#817Ferroportin inhibitors
#818ANTI-CANCER TREATMENTS WITH AN ANTI-MUC1 ANTIBODY AND AN ERBB INHIBITOR
#819RAR selective agonists in combination with immune modulators for cancer immunotherapy
#820Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#821Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
#822Compositions and Methods for Treating Neurologic Disorders
#823COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS
#824Composition and method for treating skin conditions
#825Compositions and methods for inhibiting arginase activity
#826Vitamin D, heat shock proteins, and glutathione for the treatment of chronic inflammation and chronic diseases
#827Combination Therapy for Male Sexual Dysfunction
#828Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient
#829PHARMACEUTICAL COMPOSITION AND DIETARY SUPPLEMENT COMPRISING NATURAL EXTRACTS FOR PREVENTING OR TREATING FATTY LIVER DISEASE
#830Controlled release pharmaceutical formulations of nitazoxanide
#831Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#832Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#833RAR selective agonists in combination with immune modulators for cancer immunotherapy
#834OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE
#835Treatment for non-alcoholic fatty liver diseases
#836Enzyme Replacement Therapy for Melanoma
#837BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
#838METHOD OF ENABLING MUSCLE RELAXATION
#839Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#840Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#841Polyglutamated antifolates and uses thereof
#842Compounds and methods for treating influenza
#843Materials and methods for controlling infections
#844Nucleic Acid Complexes
#845Combination immunotherapies for treatment of cancer
#846METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION
#847Methods of Administering Pirfenidone Therapy
#848Probiotic composition and feed additive
#849NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#850Stable bilayer tablet compositions
#851Compositions, combinations and related methods for photoimmunotherapy
#852Agent for use in the case of fructose intolerance
#853Treatment of Constipation-Predominant Irritable Bowel Syndrome
#854Pteridine dione monocarboxylate transporter inhibitors
#855Antiproliferative compounds and methods of use thereof
#856Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof
#857Combination comprising palmitoylethanolamide (PEA) and lycopene for use in the treatment of inflammatory diseases
#858Celecoxib and amlodipine formulation and method of making the same
#859Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor
#860Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose
#861Methods and compositions to reduce oxidative stress
#862METHOD AGAINST INFLUENZA A VIRAL INFECTION WITH TRYPTOPHAN AND ARGININE
#863METHOD OF INHIBITING HEPATOLOGICAL AND PANCREATIC DISEASES USING A SUPPLEMENT
#864Method of improving beta cell function using a supplement
#865Oxysterol-statin compounds for bone growth
#866Omega-3 fatty acid ester compositions
#867Truncated von Willebrand Factor polypeptides for treating hemophilia
#868Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#869Antiviral compounds
#870Topical ocular preparation of botulinum toxin for use in ocular surface disease
#871Compositions and methods for invasive and non-invasive procedural skincare
#872Use of Rasagiline for the Treatment of Restless Legs Syndrome
#873Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof
#874Delaying latency to seizure by combinations of ketone supplements
#875Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
#876Anti-PD-L1-anti-TIM-3 bispecific antibodies
#877Subcutaneously administered anti-IL-6 receptor antibody
#878NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#879Compositions of buprenorphine and μ antagonists
#880Treatment of infectious diseases
#881FORMULATIONS AND METHODS FOR THE TREATMENT OF CANCERS
#882Composition for improved sleep
#883Adenovirus armed with bispecific T cell engager
#884Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue
#885ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#886FLT3-specific chimeric antigen receptors and methods using same
#887Alpha polyglutamated antifolates and uses thereof
#888PAC1 antibodies and uses thereof
#889NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES
#890Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders
#891Combination therapies using HDAC inhibitors
#892Topical pharmaceutical formulation
#893Herbal nutraceutical formulation to reduce oxidative stress, viral and microbial infections, and inflammation
#894HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia
#895Treatment for ischemic stroke
#896Compound and method for treatment of movement disorders
#897APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER
#898Methods of using anti-CD79b immunoconjugates
#899DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
#900Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager